Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug
about
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic DrugsThe anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse modelMetformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent BiosynthesisRepurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agentReprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activationAnti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cellsMetformin displays in vitro and in vivo antitumor effect against osteosarcoma.TRAIL-based therapy in pediatric bone tumors: how to overcome resistance.The influence of mtDNA deletion on lung cancer cells under the conditions of hypoxia and irradiation.6-Gingerol inhibits osteosarcoma cell proliferation through apoptosis and AMPK activation.Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties.Disruption of Hif-1α enhances cytotoxic effects of metformin in murine squamous cell carcinoma.Transcriptional remodeling in response to transfer upon carbon-limited or metformin-supplemented media in S. cerevisiae and its effect on chronological life span.Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cells.How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research
P2860
Q26750845-AB76DA36-A79E-4D32-B98F-A5651634EFD0Q28539926-108ADA9F-9EC2-49B8-96E6-B761B78644ECQ28551227-E1066AA3-88E2-4033-BEBE-F4633EB3303AQ33893928-76066C2B-F9FC-4938-A156-E859C8ABE704Q33942068-C6C5BFEE-D961-4289-911A-4EBBD36910F6Q36327268-C20C62D3-A5AA-4CE6-900A-1F710CDDADFDQ37313880-5FF11421-790C-4FC8-848D-0213AFD0E796Q38352891-1F62D206-6D23-4D46-812E-720C1DB497BCQ38472624-FFBFB00C-67A1-467E-A111-37810A6734A0Q38946500-93470513-D605-47E3-AD74-EF2AB1DDA5A9Q47101870-19232F3F-D762-40F0-B54D-F1D79717A85EQ49554456-1164C503-789F-4B40-840D-78875146317BQ51619207-F46C0AE5-3E19-4805-B6BD-FC2ED006EBD7Q54109544-7228DECF-834C-491D-A58A-89EE13A8DD1AQ58695229-3792DA8F-B594-4B87-A88E-2A84B896210C
P2860
Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Metformin as an adjuvant drug ...... herapeutic effects of the drug
@ast
Metformin as an adjuvant drug ...... herapeutic effects of the drug
@en
Metformin as an adjuvant drug ...... herapeutic effects of the drug
@nl
type
label
Metformin as an adjuvant drug ...... herapeutic effects of the drug
@ast
Metformin as an adjuvant drug ...... herapeutic effects of the drug
@en
Metformin as an adjuvant drug ...... herapeutic effects of the drug
@nl
prefLabel
Metformin as an adjuvant drug ...... herapeutic effects of the drug
@ast
Metformin as an adjuvant drug ...... herapeutic effects of the drug
@en
Metformin as an adjuvant drug ...... herapeutic effects of the drug
@nl
P2860
P50
P3181
P1433
P1476
Metformin as an adjuvant drug ...... herapeutic effects of the drug
@en
P2093
Maria Cristina Manara
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0083832
P407
P50
P577
2013-12-31T00:00:00Z